ADME results22 Sep 2021 14:28
those delayed full year results are due within days.
i thought they would have done a placement by now, it but
seems i was wrong. the results should make it clearer whether
that’s because they have a much better cash position that i think,
or because they have failed to drum up any appetite for a placing.
in anticipation of those delayed full year results (to end dec 2020), to
refresh our memories, some figures from *PREVIOUS* full year results:
total number of shares for calculation of fully diluted NAV
(ordinary shares in issue + dilutive warrants) = 78, 302, 811
combined daily production from aje-4 & aje-5st2 = 2,967 bopd.
& also in the full results RNS last year, osa said that there were:
“… plans to triple production from 3,000 bpd to 9,000 bpd in 2021…”
(? so how are they getting on with that, then?)
revenue = £2,519,000
operating costs = £2,444,000
‘admin’ expenses = £1,721,000 [includes osa & BoD’s pay and perks]
loss for the year = £1,673,000
total “comprehensive income” = minus £1,945,000
(delayed full years results due by 30th sept latest, tho’ the RNS announcing that
delay said that the company was aiming to publish the results before that date.)
… meanwhile, still no sign of that CPR which was meant to take 4-6 weeks …